{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"Manufacturers Must Navigate Evolving State Approaches to Medicaid Drug Benefit Management | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"jBSuzQ6PVZ\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/manufacturers-must-navigate-evolving-state-approaches-to-medicaid-drug-benefit-management\">Manufacturers Must Navigate Evolving State Approaches to Medicaid Drug Benefit Management<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/manufacturers-must-navigate-evolving-state-approaches-to-medicaid-drug-benefit-management\/embed#?secret=jBSuzQ6PVZ\" width=\"600\" height=\"338\" title=\"&#8220;Manufacturers Must Navigate Evolving State Approaches to Medicaid Drug Benefit Management&#8221; &#8212; Avalere Health Advisory\" data-secret=\"jBSuzQ6PVZ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"[vc_row][vc_column][vc_column_text]Background Under the Medicaid Drug Rebate Program (MDRP), manufacturers are required to provide mandatory rebates and, in exchange, states must cover rebated drugs. The MDRP governs coverage and rebate requirements for all outpatient drugs in Medicaid, though states retain some flexibility in designing the drug benefit through preferred drug lists (PDLs) and utilization management (UM)&hellip;"}